Ami Fadia Analyst PerformanceAnalyst at HC WainwrightAmi Fadia is a stock analyst at HC Wainwright focused in the medical sector, covering 26 publicly traded companies. Over the past year, Ami Fadia has issued 76 stock ratings, including buy and hold recommendations. While full access to Ami Fadia's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ami Fadia's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings165 Last 6 YearsBuy Recommendations90.63% 145 Buy RatingsCompanies Covered26 Unique Companies Ratings Distribution160RatingsDistribution of strong buy, buy, hold, and sell ratings by Ami Fadia.RatingPercentageCount Strong Buy0.0%0 ratings Buy90.6%145 ratings Hold9.4%15 ratings Sell0.0%0 ratingsOut of 160 total stock ratings issued by Ami Fadia at HC Wainwright, the majority (90.6%) have been Buy recommendations, followed by 9.4% Hold.Best & Worst CallsBest Call0000.0%PRAXApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AMRNDec 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ26 companiesAmi Fadia, an analyst at HC Wainwright, currently covers 26 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical25 companies96.2%Manufacturing1 company3.8%Ami Fadia of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE18 companies69.2%MED - DRUGS5 companies19.2%Miscellaneous1 company3.8%BIOTECHNOLOGY1 company3.8%MED - OUTP/HM CRE1 company3.8% Ami Fadia's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMPLTMaplight Therapeutics7/10/2026Boost Price Target$39.80$45.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines6/29/2026Boost Price Target$327.79$575.00Buy$0.0000.00% ROIRVMDRevolution Medicines6/29/2026Boost Price Target$182.08$235.00Buy$0.0000.00% ROIBIIBBiogen6/29/2026Boost Price Target$216.03$256.00Buy$0.0000.00% ROIALKSAlkermes6/24/2026Boost Price Target$48.11$61.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics6/23/2026Boost Price Target$36.67$50.00Buy$0.0000.00% ROIMPLTMaplight Therapeutics6/22/2026Boost Price Target$30.38$42.00Buy$0.0000.00% ROIBIIBBiogen6/18/2026Reiterated Rating$198.67Buy$0.0000.00% ROIALKSAlkermes6/18/2026Boost Price Target$44.51$54.00Buy$0.0000.00% ROINMRANeumora Therapeutics6/16/2026Lower Price Target$0.91$5.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BIIBBiogen6/8/2026Upgrade$195.34$255.00Buy$0.0000.00% ROIALKSAlkermes5/6/2026Boost Price Target$36.25$50.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics5/5/2026Boost Price Target$230.28$255.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics5/1/2026Boost Price Target$205.83$255.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines4/14/2026Reiterated Rating$343.28$510.00Buy$0.0000.00% ROIMPLTMaplight Therapeutics4/8/2026Initiated Coverage$24.14$37.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences4/6/2026Reiterated Rating$133.30$185.00Buy$0.0000.00% ROINMRANeumora Therapeutics3/31/2026Reiterated Rating$1.93$8.00Buy$0.0000.00% ROICNTACentessa Pharmaceuticals3/31/2026Downgrade$27.58Hold$0.0000.00% ROIBCYCBicycle Therapeutics3/18/2026Lower Price Target$5.07$15.00Buy$0.0000.00% ROIATAIAtai Beckley3/9/2026Reiterated Rating$3.39$14.00Buy$0.0000.00% ROIIMRXImmuneering3/9/2026Reiterated Rating$5.33$11.00Buy$0.0000.00% ROIGHRSGH Research3/6/2026Boost Price Target$15.17$32.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals3/6/2026Downgrade$21.18Hold$0.0000.00% ROIDAWNDay One Biopharmaceuticals2/25/2026Lower Price Target$12.02$17.00Buy$0.0000.00% ROIHRMYHarmony Biosciences2/25/2026Lower Price Target$28.19$44.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics2/23/2026Reiterated Rating$183.72$225.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences2/12/2026Lower Price Target$137.44$185.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines2/4/2026Boost Price Target$310.52$510.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals1/12/2026Boost Price Target$161.13$235.00Buy$0.0000.00% ROIGHRSGH Research1/6/2026Set Price Target$15.46$29.00$0.0000.00% ROIPRAXPraxis Precision Medicines1/5/2026Reiterated Rating$286.40$460.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics1/5/2026Reiterated Rating$178.69$225.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals1/5/2026Reiterated Rating$26.29$34.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics1/5/2026Reiterated Rating$13.64Buy$0.0000.00% ROIGHRSGH Research1/5/2026Reiterated Rating$13.24$19.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics12/31/2025Boost Price Target$148.79$169.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/8/2025Boost Price Target$247.99$315.00Buy$0.0000.00% ROICOGTCogent Biosciences12/8/2025Reiterated Rating$39.79Hold$0.0000.00% ROIPRAXPraxis Precision Medicines12/5/2025Set Price Target$253.44$304.00$0.0000.00% ROIRay Dalio: Buy Gold. Get Paid. (Ad)Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and crypto as U.S. debt continues to climb and fiat currencies lose purchasing power. A little-known $15 fund is already converting gold's momentum into monthly income - as much as $1,152 per month. No gold bars, no mining stocks, just consistent payouts.See how to follow Dalio's gold strategy and collect monthly incomePRAXPraxis Precision Medicines12/1/2025Reiterated Rating$196.71$250.00Buy$0.0000.00% ROIHRMYHarmony Biosciences11/24/2025Reiterated Rating$34.67$42.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals11/24/2025Reiterated Rating$8.56$16.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals11/6/2025Boost Price Target$22.33$29.00Buy$0.0000.00% ROIRVMDRevolution Medicines11/6/2025Boost Price Target$59.34$72.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics11/4/2025Reiterated Rating$135.75$154.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences10/29/2025Boost Price Target$147.38$184.00Buy$0.0000.00% ROIALKSAlkermes10/29/2025Boost Price Target$31.00$44.00Buy$0.0000.00% ROINMRANeumora Therapeutics10/28/2025Boost Price Target$2.69$8.00Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals10/22/2025Downgrade$18.58Hold$0.0000.00% ROIPRAXPraxis Precision Medicines10/16/2025Boost Price Target$175.68$250.00Buy$0.0000.00% ROIGHRSGH Research10/13/2025Initiated Coverage$12.59$19.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics10/13/2025Set Price Target$11.81$28.00Buy$0.0000.00% ROIATAIAtai Beckley10/13/2025Initiated Coverage$5.10$12.00Buy$0.0000.00% ROIATAIAtai Beckley10/13/2025Initiated Coverage$5.40$12.00Buy$0.0000.00% ROIGHRSGH Research10/13/2025Initiated Coverage$12.96$19.00Buy$0.0000.00% ROIDFTXDefinium Therapeutics10/13/2025Initiated Coverage$12.25$28.00Buy$0.0000.00% ROIIMRXImmuneering9/30/2025Reiterated Rating$6.75$11.00Buy$0.0000.00% ROIMRUSMerus9/29/2025Downgrade$94.15$96.00Hold$0.0000.00% ROIBIIBBiogen9/24/2025Reiterated Rating$139.31Hold$0.0000.00% ROIHRMYHarmony Biosciences9/24/2025Lower Price Target$28.74$41.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals9/24/2025Lower Price Target$20.84$28.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences9/22/2025Boost Price Target$145.23$170.00Buy$0.0000.00% ROIIMRXImmuneering9/15/2025Boost Price Target$8.49$11.00Buy$0.0000.00% ROIRVMDRevolution Medicines9/11/2025Boost Price Target$40.45$66.00Buy$0.0000.00% ROIALKSAlkermes9/9/2025Set Price Target$26.93$43.00$0.0000.00% ROIBIIBBiogen9/4/2025Reiterated Rating$141.62Hold$0.0000.00% ROIJAZZJazz Pharmaceuticals8/28/2025Reiterated Rating$124.43$202.00Buy$0.0000.00% ROIIMRXImmuneering8/26/2025Reiterated Rating$5.95$8.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals8/20/2025Reiterated Rating$119.20$202.00Buy$0.0000.00% ROIRVMDRevolution Medicines8/7/2025Lower Price Target$36.67$56.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals8/6/2025Lower Price Target$6.88$16.00Buy$0.0000.00% ROIMRUSMerus8/6/2025Lower Price Target$67.45$96.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics8/4/2025Reiterated Rating$103.02$150.00Buy$0.0000.00% ROIALKSAlkermes7/29/2025Reiterated Rating$26.15$45.00Buy$0.0000.00% ROIALKSAlkermes7/21/2025Reiterated Rating$29.22$45.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals6/26/2025Reiterated Rating$22.50$30.00Buy$00.0000.00% ROIRVMDRevolution Medicines6/24/2025Reiterated Rating$40.42$57.00Buy$000.0000.00% ROIIMRXImmuneering6/18/2025Reiterated Rating$1.82$9.00Buy$0.0000.00% ROICOGTCogent Biosciences6/17/2025Reiterated Rating$7.49Hold$00.0000.00% ROISAGESage Therapeutics6/16/2025Reiterated Rating$6.70Hold$0.0000.00% ROIPRAXPraxis Precision Medicines6/12/2025Reiterated Rating$44.60$80.00Buy$000.0000.00% ROIBIIBBiogen6/12/2025Reiterated Rating$133.06Hold$000.0000.00% ROIJAZZJazz Pharmaceuticals6/11/2025Reiterated Rating$113.00$202.00Buy$000.0000.00% ROIAXSMAxsome Therapeutics6/9/2025Lower Price Target$111.91$150.00Buy$000.0000.00% ROIIMRXImmuneering6/5/2025Reiterated Rating$1.96$9.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals6/3/2025Reiterated Rating$108.29$202.00Buy$000.0000.00% ROIBPMCBlueprint Medicines6/2/2025Downgrade$101.15$130.00Hold$0.0000.00% ROICNTACentessa Pharmaceuticals5/28/2025Initiated Coverage$12.77$35.00Buy$00.0000.00% ROIALKSAlkermes5/28/2025Initiated Coverage$29.90$45.00Buy$00.0000.00% ROIA letter from Shannon Stansberry (Ad)Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.Watch the full story and see the verified track record for yourselfMRUSMerus5/19/2025Reiterated Rating$41.56$75.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals5/19/2025Boost Price Target$22.26$30.00Buy$00.0000.00% ROINMRANeumora Therapeutics5/13/2025Reiterated Rating$0.72$5.00Buy$0.0000.00% ROIRVMDRevolution Medicines5/8/2025Reiterated Rating$37.66$57.00Buy$000.0000.00% ROIAVDLAvadel Pharmaceuticals5/8/2025Reiterated Rating$9.47$19.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals5/7/2025Lower Price Target$6.99$27.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals5/7/2025Reiterated Rating$111.17$200.00Buy$000.0000.00% ROIHRMYHarmony Biosciences5/6/2025Reiterated Rating$29.96$49.00Buy$00.0000.00% ROIPRAXPraxis Precision Medicines5/5/2025Reiterated Rating$40.24$80.00Buy$000.0000.00% ROIBCYCBicycle Therapeutics5/2/2025Reiterated Rating$9.08$29.00Buy$0.0000.00% ROIBPMCBlueprint Medicines4/28/2025Lower Price Target$87.20$130.00Buy$0.0000.00% ROISAGESage Therapeutics4/25/2025Reiterated Rating$7.79Hold$0.0000.00% ROINBIXNeurocrine Biosciences4/15/2025Upgrade$94.89$138.00Buy$000.0000.00% ROIJAZZJazz Pharmaceuticals4/10/2025Reiterated Rating$110.12$210.00Buy$000.0000.00% ROIIMRXImmuneering4/10/2025Reiterated Rating$1.29$12.00Buy$0.0000.00% ROINMRANeumora Therapeutics4/10/2025Reiterated Rating$0.76$5.00Buy$0.0000.00% ROIAVDLAvadel Pharmaceuticals4/9/2025Reiterated Rating$6.59$19.00Buy$0.0000.00% ROIMRUSMerus4/9/2025Reiterated Rating$34.89$83.00Buy$0.0000.00% ROIBCYCBicycle Therapeutics4/9/2025Reiterated Rating$6.38$30.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals4/8/2025Reiterated Rating$14.61$28.00Buy$00.0000.00% ROIBPMCBlueprint Medicines4/8/2025Reiterated Rating$80.20$133.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines4/8/2025Reiterated Rating$31.53$85.00Buy$000.0000.00% ROIRVMDRevolution Medicines4/8/2025Reiterated Rating$31.40$59.00Buy$00.0000.00% ROIHRMYHarmony Biosciences4/8/2025Reiterated Rating$28.91$50.00Buy$00.0000.00% ROIAXSMAxsome Therapeutics4/1/2025Reiterated Rating$116.63$153.00Buy$000.0000.00% ROIIMRXImmuneering3/21/2025Reiterated Rating$1.65$12.00Buy$0.0000.00% ROIBCYCBicycle Therapeutics3/11/2025Reiterated Rating$9.79$30.00Buy$0.0000.00% ROIJAZZJazz Pharmaceuticals3/5/2025Reiterated Rating$140.69$210.00Buy$000.0000.00% ROINMRANeumora Therapeutics3/4/2025Reiterated Rating$1.41$5.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines3/3/2025Lower Price Target$38.60$85.00Buy$000.0000.00% ROIAVDLAvadel Pharmaceuticals3/3/2025Reiterated Rating$7.91$19.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics3/3/2025Reiterated Rating$129.15$153.00Buy$000.0000.00% ROIMRUSMerus2/28/2025Lower Price Target$46.22$83.00Buy$0.0000.00% ROIACADACADIA Pharmaceuticals2/27/2025Reiterated Rating$18.96$28.00Buy$00.0000.00% ROIRVMDRevolution Medicines2/27/2025Lower Price Target$40.50$59.00Buy$000.0000.00% ROIBCYCBicycle Therapeutics2/26/2025Reiterated Rating$11.10$30.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals2/26/2025Reiterated Rating$11.82$32.00Buy$00.0000.00% ROIJAZZJazz Pharmaceuticals2/26/2025Boost Price Target$139.67$210.00Buy$000.0000.00% ROIHRMYHarmony Biosciences2/25/2025Reiterated Rating$34.18$50.00Buy$00.0000.00% ROIAXSMAxsome Therapeutics2/19/2025Boost Price Target$128.09$153.00Buy$000.0000.00% ROIHRMYHarmony Biosciences2/19/2025Lower Price Target$36.76$50.00Buy$00.0000.00% ROIBPMCBlueprint Medicines2/13/2025Reiterated Rating$103.56$133.00Buy$0.0000.00% ROISAGESage Therapeutics2/12/2025Reiterated Rating$7.19Hold$0.0000.00% ROIPRAXPraxis Precision Medicines2/10/2025Reiterated Rating$86.88$150.00Buy$000.0000.00% ROIAXSMAxsome Therapeutics2/10/2025Reiterated Rating$131.74$133.00Buy$000.0000.00% ROINBIXNeurocrine Biosciences2/7/2025Reiterated Rating$150.51Hold$000.0000.00% ROIIMRXImmuneering2/6/2025Reiterated Rating$2.03$12.00Buy$0.0000.00% ROIBPMCBlueprint Medicines1/13/2025Reiterated Rating$87.43$135.00Buy$0.0000.00% ROIHRMYHarmony Biosciences1/13/2025Reiterated Rating$35.91$52.00Buy$00.0000.00% ROIBCYCBicycle Therapeutics1/13/2025Reiterated Rating$14.75$32.00Buy$0.0000.00% ROISell Tesla, Buy the New King of FSD Cars (Ad)In 2023, Marc Chaikin's system flagged an automotive stock as bearish - and it fell 35% shortly after. Today, that same stock has earned a 'Very Bullish' rating after forming a major partnership with Nvidia to power AI-driven autonomous vehicles. This barely-known company was selected to handle the complex job of getting Nvidia's self-driving AI safely inside vehicles - positioning it at the center of a massive trend most investors are still missing through Tesla.Get the company's name and ticker free before it goes mainstreamIMRXImmuneering1/13/2025Reiterated Rating$1.99$15.00Buy$0.0000.00% ROIDAWNDay One Biopharmaceuticals1/13/2025Reiterated Rating$11.77$33.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysMorgan StanleyRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftRaymond James FinancialStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.